Literature DB >> 10780941

Citrate release by perfused rat hearts: a window on mitochondrial cataplerosis.

G Vincent1, B Comte, M Poirier, C D Rosiers.   

Abstract

Cytosolic citrate is proposed to play a crucial role in substrate fuel selection in the heart. However, little is known about factors regulating the transfer of citrate from the mitochondria, where it is synthesized, to the cytosol. Further to our observation that rat hearts perfused under normoxia release citrate whose (13)C labeling pattern reflects that of mitochondrial citrate (B. Comte, G. Vincent, B. Bouchard, and C. Des Rosiers. J. Biol. Chem. 272: 26117-26124, 1997), we report here data indicating that this citrate release is a specific process reflecting the mitochondrial efflux of citrate, a process referred to as cataplerosis. Indeed, measured rates of citrate release, which vary between 2 and 21 nmol/min, are modulated by the nature and concentration of exogenous substrates feeding acetyl-CoA (fatty acid) and oxaloacetate (lactate plus pyruvate) for the mitochondrial citrate synthase reaction. Such release rates that represent at most 2% of the citric acid cycle flux are in agreement with the activity of the mitochondrial tricarboxylate transporter whose participation is also substantiated by 1) parallel variations in citrate release rates and tissue levels of citrate plus malate, the antiporter, and 2) a lowering of the citrate release rate by 1,2, 3-benzenetricarboxylic acid, a specific inhibitor of the transporter. Taken together, the results from the present study indicate that citrate cataplerosis is modulated by substrate supply, in agreement with the role of cytosolic citrate in fuel partitioning, and occurs, at least in part, through the mitochondrial tricarboxylate transporter.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10780941     DOI: 10.1152/ajpendo.2000.278.5.E846

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  11 in total

1.  Skeletal muscle interstitial fluid metabolomics at rest and associated with an exercise bout: application in rats and humans.

Authors:  Jie Zhang; Sudeepa Bhattacharyya; Robert C Hickner; Alan R Light; Christopher J Lambert; Bruce K Gale; Oliver Fiehn; Sean H Adams
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-11-06       Impact factor: 4.310

2.  Lysine Acetylation Activates Mitochondrial Aconitase in the Heart.

Authors:  Jolyn Fernandes; Alexis Weddle; Caroline S Kinter; Kenneth M Humphries; Timothy Mather; Luke I Szweda; Michael Kinter
Journal:  Biochemistry       Date:  2015-06-19       Impact factor: 3.162

3.  Metabolic phenotyping of the diseased rat heart using 13C-substrates and ex vivo perfusion in the working mode.

Authors:  Geneviève Vincent; Maya Khairallah; Bertrand Bouchard; Christine Des Rosiers
Journal:  Mol Cell Biochem       Date:  2003-01       Impact factor: 3.396

Review 4.  Cardiac anaplerosis in health and disease: food for thought.

Authors:  Christine Des Rosiers; François Labarthe; Steven G Lloyd; John C Chatham
Journal:  Cardiovasc Res       Date:  2011-03-11       Impact factor: 10.787

Review 5.  Matrix revisited: mechanisms linking energy substrate metabolism to the function of the heart.

Authors:  Andrew N Carley; Heinrich Taegtmeyer; E Douglas Lewandowski
Journal:  Circ Res       Date:  2014-02-14       Impact factor: 17.367

6.  Fatty acid chain elongation in palmitate-perfused working rat heart: mitochondrial acetyl-CoA is the source of two-carbon units for chain elongation.

Authors:  Janos Kerner; Paul E Minkler; Edward J Lesnefsky; Charles L Hoppel
Journal:  J Biol Chem       Date:  2014-02-20       Impact factor: 5.157

7.  A comparison between NMR and GCMS 13C-isotopomer analysis in cardiac metabolism.

Authors:  John C Chatham; Bertrand Bouchard; Christine Des Rosiers
Journal:  Mol Cell Biochem       Date:  2003-07       Impact factor: 3.396

8.  Exercise plasma metabolomics and xenometabolomics in obese, sedentary, insulin-resistant women: impact of a fitness and weight loss intervention.

Authors:  Dmitry Grapov; Oliver Fiehn; Caitlin Campbell; Carol J Chandler; Dustin J Burnett; Elaine C Souza; Gretchen A Casazza; Nancy L Keim; John W Newman; Gary R Hunter; Jose R Fernandez; W Timothy Garvey; Charles L Hoppel; Mary-Ellen Harper; Sean H Adams
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-09-17       Impact factor: 4.310

9.  Determining the in vivo regulation of cardiac pyruvate dehydrogenase based on label flux from hyperpolarised [1-13C]pyruvate.

Authors:  Marie A Schroeder; Helen J Atherton; Lisa C Heather; Julian L Griffin; Kieran Clarke; George K Radda; Damian J Tyler
Journal:  NMR Biomed       Date:  2011-03-08       Impact factor: 4.044

10.  Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway.

Authors:  Houman Ashrafian; Gabor Czibik; Mohamed Bellahcene; Dunja Aksentijević; Anthony C Smith; Sarah J Mitchell; Michael S Dodd; Jennifer Kirwan; Jonathan J Byrne; Christian Ludwig; Henrik Isackson; Arash Yavari; Nicolaj B Støttrup; Hussain Contractor; Thomas J Cahill; Natasha Sahgal; Daniel R Ball; Rune I D Birkler; Iain Hargreaves; Daniel A Tennant; John Land; Craig A Lygate; Mogens Johannsen; Rajesh K Kharbanda; Stefan Neubauer; Charles Redwood; Rafael de Cabo; Ismayil Ahmet; Mark Talan; Ulrich L Günther; Alan J Robinson; Mark R Viant; Patrick J Pollard; Damian J Tyler; Hugh Watkins
Journal:  Cell Metab       Date:  2012-03-07       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.